A TO in this environment right now is not a strategic option I would have thought would be a good idea. Why pay for something now, when you can wait and get it for cheaper?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025